June 17, 2021
Astellas Pharma said on June 16 that it will divest five legacy products sold in certain countries of Europe, Russia, Commonwealth of Independent States (CIS), and Asia to German drug maker Cheplapharm Arzneimittel for €95 million. The two companies concluded...read more